User login
The Challenging World of the Diagnosis and Treatment of Vascular Malformations: An Orphan Disease that Has Now Come of Age
(Sessions 92-98; Friday, 6:45 a.m. to 1:30 p.m.)
Location: Gramercy Suites East and West, 2nd Floor
Vascular malformations constitute one of the most challenging clinical entities encountered in Vascular Medicine today. They can occur in every anatomy in the body insinuating themselves throughout an organ or tissue. Being totally comprised of vascular structures, any surgical attempt at resection is fraught with potential hemorrhagic complications. Compounding their inherent difficulty in management , they are also very rare entities. The clinical presentations are extremely protean and can range from an asymptomatic birthmark, to fulminant, life-threatening CHF. Attributing any of these extremely varied symptoms that a patient may present with to a vascular malformation can be challenging to the most experienced clinician. Patients typically bounce from clinician to clinician experiencing disappointing outcomes, complications, and recurrence or worsening of their presenting symptoms. Due to their extreme rarity (>1% of the population), it is difficult for clinicians to gain any experience at all in their diagnosis and optimal management and make definitive statements.
The purpose of these Vascular Malformation Sessions is to offer the attendee the current state-of-the-art multi-disciplinary endovascular and surgical approaches to accurately diagnose and optimally treat all types of vascular malformations (AVMs, AVFs, venous malformations, lymphatic malformations, capillary-venous malformations, and mixed lesions) in all the various problematic anatomies in which they occur. Being that there are controversies regarding the various treatment strategies regarding vascular malformations, the attendees will be exposed to those multiple approaches and philosophies regarding the science, the multiple management strategies, the results, the long-term outcomes, and the complications inherent in the various palliative and curative treatments proffered by international experts.
Improving Outcomes in Hemodialysis Access
(Sessions 106-110; Saturday; 7:55 a.m. – 4:00 p.m.) Registration Begins At 6:00 a.m.
Location: Grand Ballroom West, 3rd Floor
The Hemodialysis Access sessions on Saturday (Sessions 106 – 110) will include presentations on planning, optimizing outcomes, political, economic and legal issues, new technologies and an update on clinical issues related to hemodialysis access. Experts will address specific topics including vein preservation and planning for access, use of ultrasound to facilitate cannulation, use of simulators, the role of drug eluting balloons and stents, management of complications including steal syndrome, infections and access hemorrhage, coding for access procedures, pharmacologic and mechanical approaches to improve fistula outcomes, treatment of fistula aneurysms, use of the HeRO graft and many more important topics. The keynote speaker will be Dr. Michael Brescia who will give his unique historical perspective on the development of the AV fistula. This session should be of interest to surgeons, nephrologists, interventionalists, nurses, dialysis technicians and others interested in the care of patients with end stage renal disease.
The Challenging World of the Diagnosis and Treatment of Vascular Malformations: An Orphan Disease that Has Now Come of Age
(Sessions 92-98; Friday, 6:45 a.m. to 1:30 p.m.)
Location: Gramercy Suites East and West, 2nd Floor
Vascular malformations constitute one of the most challenging clinical entities encountered in Vascular Medicine today. They can occur in every anatomy in the body insinuating themselves throughout an organ or tissue. Being totally comprised of vascular structures, any surgical attempt at resection is fraught with potential hemorrhagic complications. Compounding their inherent difficulty in management , they are also very rare entities. The clinical presentations are extremely protean and can range from an asymptomatic birthmark, to fulminant, life-threatening CHF. Attributing any of these extremely varied symptoms that a patient may present with to a vascular malformation can be challenging to the most experienced clinician. Patients typically bounce from clinician to clinician experiencing disappointing outcomes, complications, and recurrence or worsening of their presenting symptoms. Due to their extreme rarity (>1% of the population), it is difficult for clinicians to gain any experience at all in their diagnosis and optimal management and make definitive statements.
The purpose of these Vascular Malformation Sessions is to offer the attendee the current state-of-the-art multi-disciplinary endovascular and surgical approaches to accurately diagnose and optimally treat all types of vascular malformations (AVMs, AVFs, venous malformations, lymphatic malformations, capillary-venous malformations, and mixed lesions) in all the various problematic anatomies in which they occur. Being that there are controversies regarding the various treatment strategies regarding vascular malformations, the attendees will be exposed to those multiple approaches and philosophies regarding the science, the multiple management strategies, the results, the long-term outcomes, and the complications inherent in the various palliative and curative treatments proffered by international experts.
Improving Outcomes in Hemodialysis Access
(Sessions 106-110; Saturday; 7:55 a.m. – 4:00 p.m.) Registration Begins At 6:00 a.m.
Location: Grand Ballroom West, 3rd Floor
The Hemodialysis Access sessions on Saturday (Sessions 106 – 110) will include presentations on planning, optimizing outcomes, political, economic and legal issues, new technologies and an update on clinical issues related to hemodialysis access. Experts will address specific topics including vein preservation and planning for access, use of ultrasound to facilitate cannulation, use of simulators, the role of drug eluting balloons and stents, management of complications including steal syndrome, infections and access hemorrhage, coding for access procedures, pharmacologic and mechanical approaches to improve fistula outcomes, treatment of fistula aneurysms, use of the HeRO graft and many more important topics. The keynote speaker will be Dr. Michael Brescia who will give his unique historical perspective on the development of the AV fistula. This session should be of interest to surgeons, nephrologists, interventionalists, nurses, dialysis technicians and others interested in the care of patients with end stage renal disease.
The Challenging World of the Diagnosis and Treatment of Vascular Malformations: An Orphan Disease that Has Now Come of Age
(Sessions 92-98; Friday, 6:45 a.m. to 1:30 p.m.)
Location: Gramercy Suites East and West, 2nd Floor
Vascular malformations constitute one of the most challenging clinical entities encountered in Vascular Medicine today. They can occur in every anatomy in the body insinuating themselves throughout an organ or tissue. Being totally comprised of vascular structures, any surgical attempt at resection is fraught with potential hemorrhagic complications. Compounding their inherent difficulty in management , they are also very rare entities. The clinical presentations are extremely protean and can range from an asymptomatic birthmark, to fulminant, life-threatening CHF. Attributing any of these extremely varied symptoms that a patient may present with to a vascular malformation can be challenging to the most experienced clinician. Patients typically bounce from clinician to clinician experiencing disappointing outcomes, complications, and recurrence or worsening of their presenting symptoms. Due to their extreme rarity (>1% of the population), it is difficult for clinicians to gain any experience at all in their diagnosis and optimal management and make definitive statements.
The purpose of these Vascular Malformation Sessions is to offer the attendee the current state-of-the-art multi-disciplinary endovascular and surgical approaches to accurately diagnose and optimally treat all types of vascular malformations (AVMs, AVFs, venous malformations, lymphatic malformations, capillary-venous malformations, and mixed lesions) in all the various problematic anatomies in which they occur. Being that there are controversies regarding the various treatment strategies regarding vascular malformations, the attendees will be exposed to those multiple approaches and philosophies regarding the science, the multiple management strategies, the results, the long-term outcomes, and the complications inherent in the various palliative and curative treatments proffered by international experts.
Improving Outcomes in Hemodialysis Access
(Sessions 106-110; Saturday; 7:55 a.m. – 4:00 p.m.) Registration Begins At 6:00 a.m.
Location: Grand Ballroom West, 3rd Floor
The Hemodialysis Access sessions on Saturday (Sessions 106 – 110) will include presentations on planning, optimizing outcomes, political, economic and legal issues, new technologies and an update on clinical issues related to hemodialysis access. Experts will address specific topics including vein preservation and planning for access, use of ultrasound to facilitate cannulation, use of simulators, the role of drug eluting balloons and stents, management of complications including steal syndrome, infections and access hemorrhage, coding for access procedures, pharmacologic and mechanical approaches to improve fistula outcomes, treatment of fistula aneurysms, use of the HeRO graft and many more important topics. The keynote speaker will be Dr. Michael Brescia who will give his unique historical perspective on the development of the AV fistula. This session should be of interest to surgeons, nephrologists, interventionalists, nurses, dialysis technicians and others interested in the care of patients with end stage renal disease.